These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 23108522)

  • 21. A review of oral anticoagulants in patients with atrial fibrillation.
    Greenspon AJ
    Postgrad Med; 2012 Nov; 124(6):7-16. PubMed ID: 23322134
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rivaroxaban in the contemporary treatment of acute coronary syndromes.
    Alexander D; Jeremias A
    Expert Opin Investig Drugs; 2011 Jun; 20(6):849-57. PubMed ID: 21554163
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Rivaroxaban in non valvular atrial fibrillation: subgroups analysis].
    Greco C
    Monaldi Arch Chest Dis; 2014 Mar; 82(1):16-9. PubMed ID: 25481935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Warfarin use and outcomes in patients with atrial fibrillation complicating acute coronary syndromes.
    Lopes RD; Starr A; Pieper CF; Al-Khatib SM; Newby LK; Mehta RH; Van de Werf F; Mahaffey KW; Armstrong PW; Harrington RA; White HD; Wallentin L; Granger CB
    Am J Med; 2010 Feb; 123(2):134-40. PubMed ID: 20103022
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atrial fibrillation--not so NICE in Ireland!
    Collins DR; Coughlan T
    Ir Med J; 2012; 105(7):229-31. PubMed ID: 23008880
    [No Abstract]   [Full Text] [Related]  

  • 26. [Atrial fibrillation: what the GP needs to know].
    Diener HC; Kaeufer T; Bode C
    MMW Fortschr Med; 2011 Sep; 153(38):44-7; quiz 48. PubMed ID: 21977796
    [No Abstract]   [Full Text] [Related]  

  • 27. New anticoagulant drugs for treatment of venous thromboembolism and stroke prevention in atrial fibrillation.
    Tripodi A; Palareti G
    J Intern Med; 2012 Jun; 271(6):554-65. PubMed ID: 22443239
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apixaban in other situations?
    Prescrire Int; 2012 Sep; 21(130):203. PubMed ID: 23016248
    [No Abstract]   [Full Text] [Related]  

  • 29. Dabigatran versus rivaroxaban for the prevention of stroke and systemic embolism in atrial fibrillation in Canada. Comparative efficacy and cost-effectiveness.
    Kansal AR; Sharma M; Bradley-Kennedy C; Clemens A; Monz BU; Peng S; Roskell N; Sorensen SV
    Thromb Haemost; 2012 Oct; 108(4):672-82. PubMed ID: 22898892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angioedema due to the new oral anticoagulant rivaroxaban.
    Altin C; Ozturkeri OA; Gezmis E; Askin U
    Ann Card Anaesth; 2014; 17(2):173-4. PubMed ID: 24732626
    [No Abstract]   [Full Text] [Related]  

  • 31. Intravenous thrombolysis in stroke patients receiving rivaroxaban.
    Seiffge DJ; Traenka C; Gensicke H; Tsakiris DA; Bonati LH; Peters N; Lyrer P; Engelter ST
    Eur J Neurol; 2014; 21(1):e3-4. PubMed ID: 25133279
    [No Abstract]   [Full Text] [Related]  

  • 32. Rivaroxaban (Xarelto) for acute coronary syndrome.
    Med Lett Drugs Ther; 2011 Dec; 53(1379-1380):97. PubMed ID: 22173426
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A new era for anticoagulation in atrial fibrillation.
    Mega JL
    N Engl J Med; 2011 Sep; 365(11):1052-4. PubMed ID: 21870977
    [No Abstract]   [Full Text] [Related]  

  • 34. Evaluating rivaroxaban for nonvalvular atrial fibrillation--regulatory considerations.
    Fleming TR; Emerson SS
    N Engl J Med; 2011 Oct; 365(17):1557-9. PubMed ID: 21992495
    [No Abstract]   [Full Text] [Related]  

  • 35. Reconsideration of anticoagulant therapy in Japanese patients with atrial fibrillation and moderate renal impairment.
    Shiga T
    Circ J; 2013; 77(3):596-7. PubMed ID: 23363645
    [No Abstract]   [Full Text] [Related]  

  • 36. [Anticoagulants and dual antiplatelet therapy combined, a challenge to our intelligence].
    Morais J
    Rev Port Cardiol; 2012 Apr; 31 Suppl 1():38-44. PubMed ID: 22541034
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New and emerging anticoagulant therapy for atrial fibrillation and acute coronary syndrome.
    Davis EM; Packard KA; Knezevich JT; Campbell JA
    Pharmacotherapy; 2011 Oct; 31(10):975-1016. PubMed ID: 21950643
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spontaneus splenic rupture in a patient treated with rivaroxaban.
    Gonzva J; Patricelli R; Lignac D
    Am J Emerg Med; 2014 Aug; 32(8):950.e3. PubMed ID: 24612597
    [No Abstract]   [Full Text] [Related]  

  • 39. [Rivaroxaban versus warfarin: results of the ROCKET study].
    Lipták J
    Ideggyogy Sz; 2012 Sep; 65(9-10):349-51. PubMed ID: 23126221
    [No Abstract]   [Full Text] [Related]  

  • 40. Thrombocardiology: an update.
    Arnesen H
    Expert Rev Cardiovasc Ther; 2010 Mar; 8(3):331-3. PubMed ID: 20222811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.